Shopping Cart
Remove All
Your shopping cart is currently empty
ALC-0159 is a polyethylene glycol (PEG) lipid conjugate that could be used as a vaccine excipient[1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $55 | In Stock | In Stock | |
| 10 mg | $89 | In Stock | In Stock | |
| 25 mg | $155 | - | In Stock | |
| 50 mg | $278 | - | In Stock | |
| 100 mg | $413 | - | In Stock | |
| 200 mg | $615 | - | In Stock |
| Description | ALC-0159 is a polyethylene glycol (PEG) lipid conjugate that could be used as a vaccine excipient[1]. |
| In vitro | ALC-0159 promotes nanoparticle stabilization by a steric mechanism through its poly(ethylene glycol) (PEG) moiety[1]. |
| Formula | (C2H4O)nC31H63NO2 |
| Cas No. | 1849616-42-7 |
| Smiles | N.CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(=O)COCCOC |
| Relative Density. | 1.31g/cm3 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility Information | DMSO: 18.33 mg/mL (33.77 mM), Sonication is recommended. |
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL, Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.